While treatment of pulmonary infections by Mycobacterium tuberculosis is currently only rarely the cause of iatrogenic complications, treatment of atypical mycobacterial infections often requires prolonged treatment duration, which can lead to toxic optic neuropathies. This review summarizes the indications for such prolonged treatment and risk factors for toxic optic neuropathies when using ethambutol, isoniazid and/or linezolid and proposes customized screening recommendations.
Keywords: Atypical mycobacteria; Dépistage; Ethambutol; Isoniazid; Isoniazide; Linezolid; Linézolide; Mycobactérie atypique; Neuropathie optique toxique; OCT; Screening; Toxic optic neuropathy; Tuberculose; Tuberculosis; Éthambutol.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.